Medical Affairs & Social Media in Immunology

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Non-members: Click here to review a complimentary excerpt from “Medical’s Road Map for Social Media Success in Immunology: Structure and Activities”

STUDY OVERVIEW

Immunology manufacturers recognize the enormous potential social media holds in engaging with key stakeholders such as healthcare providers, thought leaders, patients, and digital opinion leaders. However, for Medical Affairs leaders to effectively engage their target audience, they must establish the appropriate organizational structure and activities.

Best Practices, LLC undertook benchmarking research to develop a roadmap for Medical Affairs' social media success in Immunology. The study examines the optimal structure for Medical Affairs groups within Immunology companies to engage in social media initiatives and emphasizes key social media activities to effectively educate the market.

The research provides benchmarks around social media account quantity, separation of accounts, share of account ownership, medical affairs involvement, vendor utilization, social media platforms utilized, target audiences, social media goals, proactive vs. reactive interaction proportions, and proactive social media activities for medical.

KEY TOPICS

Social Media Structure
Social Media Management in Immunology
Social Media Activities

KEY METRICS

What is the geographic span of responsibility of benchmarked Immunology organizations?
Do Immunology organizations have a single social media account or multiple?
What is the range of multiple social media accounts?
Please indicate how the organization’s social media accounts are separated
To what degree does Medical Affairs share social media accounts with other groups in the organization?
Do Immunology Medical Affairs groups partner with third party vendors to support or drive social media activities?
Please indicate the social media platforms which are utilized by Immunology Medical Affairs groups
Which groups are target audiences for Medical’s social media activities?
To what degree is the Medical Affairs function involved in social media initiatives at Immunology organizations?
Which goals are priorities for Medical Affairs group’s social media efforts?
What percentage of Medical Affairs’ social media engagements are currently proactive vs. reactive?
Please specify the proactive activities Immunology Medical Affairs group perform through their social media accounts
Please indicate how effective each social media platform is for each of the listed proactive activities
Please rate the effectiveness of proactive social media activities in engaging each target audience

SAMPLE KEY FINDINGS

Social Media Accounts: The consensus is that multiple avenues of outreach are most effective: The social scorecard shows multiple accounts maintained by the entire Immunology segment and 68% of the rest of the benchmark class.

METHODOLOGY

Best Practices, LLC engaged 48 Medical leaders from 36 biopharma companies in this benchmarking research. For immunology therapeutic area-specific insights, two specific segments were investigated in this study: Responses from 10 social media leaders at 10 Immunology organizations were analyzed against the rest of the total benchmark class.

Industries Profiled:
Pharmaceutical; Biotech; Medical Device; Manufacturing; Consumer Products; Diagnostic; Communications; Medical; Biopharmaceutical; Health Care; Consulting

Companies Profiled:
AbbVie; Avidity Biosciences; AstraZeneca; Baxter Healthcare; Bayer; BIAL; Boehringer Ingelheim; Boston Scientific; Complete HealthVizion | An IPG Health Company; Domp�; DURECT Corporation; Eisai; Elevation Oncology; EMD Serono; Ethicon Endo-Surgery Inc.; Gossamer Bio; Grifols; Hoya Vision Care; Janssen; LEO Pharma; MedVal Scientific Information Services; Merck KGaA; Merck Sharp & Dohme; Merz Pharma; Merz Aesthetics; Myovant Sciences; Nobel Biocare; Novartis; Novartis Oncology; Novo Nordisk; PRECISIONscientia; Servier; Supernus; Takeda Pharmaceuticals; Teva Pharmaceutical Industries Ltd; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Medical’s Road Map for Social Media Success in Immunology: Structure and Activities

ID: 5758

Features:

Pages/Slides: 34

Published: 2023

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6E740C1B706B867FE0025899B00319CFC
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-medicals-road-map-for-social-media-success-immunology-structure-activities?opendocument
18
19opendocument
203.239.76.211
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB